PUBPAT Advocacy to the PTO, Others
PUBPAT advocates for sound patent policy before the U. S. Patent and Trademark Office and many other policy makers.
Click Here to See PUBPAT in Congress
Comments to the U.S. Patent & Trademark Office
- European Commission
- Gowers Review of Intellectual Property
- National Institutes of Health (NIH)
Related News
- December 20, 2007: Consumer and Public Interest Groups Back New U.S. Patent Rules That Would Curtail Abusive Behavior By Applicants
- March 20, 2009: APPEALS COURT RULES IN FAVOR OF NEW U.S. PATENT OFFICE RULE SUPPORTED BY PUBPAT: Proposed Regulation Would Help Curtail Abusive Behavior By Patent Applicants
- July 29, 2008: PUBLIC INTEREST GROUPS BACK FEDERAL COURT APPEAL TO IMPLEMENT NEW U.S. PATENT RULES: Proposed Regulations Would Curtail Abusive Behavior By Patent Applicants
- December 20, 2007: Consumer and Public Interest Groups Back New U.S. Patent Rules That Would Curtail Abusive Behavior By Applicants
- November 11, 2004: PUBPAT EXECUTIVE DIRECTOR DETAILS PROBLEMS WITH AND HARM CAUSED BY SOFTWARE PATENTS: Dan Ravicher Speaks in the European Parliament As Part of Foundation for a Free Information Infrastructure Conference
- May 24, 2004: PUBPAT EXECUTIVE DIRECTOR TESTIFIES BEFORE NIH REGARDING KEY AIDS DRUG PATENTS: PUBPAT Supports Request Asking Government to Allow the Production of Generic Drug
- February 24, 2004: PUBPAT PROVIDES COMMENTS TO USPTO ON INTER PARTES REEXAMINATION AND RULES GOVERNING PRACTITIONERS: Argues All Patents Should be Subject to Adversarial Post Grant Review and All Patent Attorneys Should Have Continuing Education Requirements